Titre :

Long-term benzodiazepine prescription in treatment-resistant depression: A national FACE-TRD prospective study.

Auteur(s) :

Fond, G. [Auteur]
Faugere, M. [Auteur]
Boyer, L. [Auteur]
Peri, P. [Auteur]
Stephan, F. [Auteur]
Moliere, F. [Auteur]
Anguill, L. [Auteur]
Bennabi, D. [Auteur]
Haffen, E. [Auteur]
Bouvard, A. [Auteur]
Walter, M. [Auteur]
Samalin, L. [Auteur]
Llorca, P. M. [Auteur]
Genty, J. B. [Auteur]
Leboyer, M. [Auteur]
Holtzmann, J. [Auteur]
Nguon, A. S. [Auteur]
Rey, R. [Auteur]
Horn, Mathilde [Auteur]
Lille Neurosciences & Cognition (LilNCog) - U 1172
Vaiva, Guillaume [Auteur]
Lille Neurosciences & Cognition (LilNCog) - U 1172
Hennion, V. [Auteur]
Etain, B. [Auteur]
El-Hage, W. [Auteur]
Camus, V. [Auteur]
Courtet, P. [Auteur]
Aouizerate, B. [Auteur]
Yrondi, A. [Auteur]
Lancon, C. [Auteur]
Richieri, R. [Auteur]

Titre de la revue :

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Numéro :

126

Pagination :

110779

Éditeur :

Elsevier

Date de publication :

2023-04-30

ISSN :

1878-4216

Mot(s)-clé(s) :

Public health
Mental health
Psychiatry
Depression
Depressive disorders
treatment-resistant
Benzodiazepine
Addiction

Discipline(s) HAL :

Sciences du Vivant [q-bio]

Résumé en anglais : [en]

Background Benzodiazepine long-term use (BLTU) is a public health challenge. We lack data on the consequences of LBTU on the trajectory of treatment-resistant depression (TRD). Objective To determine the prevalence ...
Lire la suite >Background Benzodiazepine long-term use (BLTU) is a public health challenge. We lack data on the consequences of LBTU on the trajectory of treatment-resistant depression (TRD). Objective To determine the prevalence of BLTU in a nationwide non-selected population of patients with TRD, to determine the rate of patients succeeding at withdrawing benzodiazepines at one year and to determine if persistent BLTU is associated with poorer mental health outcomes. Method The FACE-TRD cohort is a national cohort of TRD patients recruited in 13 resistant depression expert centers between 2014 and 2021 and followed-up at one year. A standardized one-day long comprehensive battery was carried out, including trained-clinician and patient-reported outcomes, and patients were reevaluated at one year. Results At baseline, 45.2% of the patients were classified in the BLTU group. In multivariate analysis, compared to patients without BLTU, patients with BLTU were more frequently classified in the “low physical activity” group (adjusted odds ratio (aOR) = 1.885, p = 0.036), and had higher primary healthcare consumption (B = 0.158, p = 0.031) independently of age, sex and antipsychotic consumption. We found no significant difference for personality traits, suicidal ideation, impulsivity, childhood trauma exposure, earlier age at first major depressive episode, anxiety and sleep disorders (all p > 0.05). Despite recommendations for withdrawal, <5% of BLTU patients withdraw benzodiazepines during the one-year follow-up. Persistent BLTU at one-year was associated with higher depression severity (B = 0.189, p = 0.029), higher clinical global severity (B = 0.210, p = 0.016), higher state-anxiety (B = 0.266, p = 0.003), impaired sleep quality (B = 0.249, p = 0.008), increased peripheral inflammation (B = 0.241, p = 0.027), lower functioning level (B = -0.240, p = 0.006), decreased processing speed (B = -0.195, p = 0.020) and verbal episodic memory (B = -0.178, p = 0.048), higher absenteeism and productivity loss (B = 0.595, p = 0.016) and lower subjective global health status (B = -0.198, p = 0.028). Conclusion Benzodiazepines are over-prescribed in TRD (in almost a half of the patients). Despite recommendations for withdrawal and psychiatric follow-up, <5% of patients successfully stopped taking benzodiazepines at one-year. Maintaining BLTU may contribute to the worsening of clinical and cognitive symptoms and of daily functioning in TRD patients. Progressive and planed withdrawal of benzodiazepines seems therefore strongly recommended in TRD patients with BLTU. Pharmacological and non-pharmacological alternatives should be promoted when possible.Lire moins >

Langue :

Anglais

Audience :

Internationale

Vulgarisation :

Non

Établissement(s) :

Université de Lille
Inserm
CHU Lille

Collections :

• Lille Neurosciences & Cognition (LilNCog) - U 1172

Date de dépôt :

2024-01-15T23:02:48Z
2024-09-11T08:03:01Z